1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Headaches: Current Treatments, Unmet Needs, and Patient Recruitment

Headaches: Current Treatments, Unmet Needs, and Patient Recruitment

  • March 2014
  • -
  • Industry Standard Research
  • -
  • 160 pages

ISR identifies and explores the patterns and preferences surrounding the needs, treatments, and side-effects of patients living with chronic cluster headaches, tension headaches, and migraines. This report provides pharmaceutical and biotech companies and their service providers with an opportunity to position their product, enhance clinical development planning, and improve clinical trial patient recruitment.

How you can use this report:
Methodology and Reporting:
- Quickly get a baseline for “a day in the life” of a severe headache sufferer. Learn about their conditions, quality of life, headache triggers, unmet needs, and treatment satisfaction
- Talk their language and design your marketing and advertising plans to account for the current issues and unmet patient needs
- Improve protocol design and patient recruitment efforts by incorporating socio-economic and treatment-specific messages into your plans
- Understand what types of physicians patients are seeing and what is impacting their medication treatment decisions
- And more See the full table of contents in this preview for a full list of topics covered in this report

Methodology and Reporting:
- Quickly get a baseline for “a day in the life” of a severe headache sufferer. Learn about their conditions, quality of life, headache triggers, unmet needs, and treatment satisfaction
- Talk their language and design your marketing and advertising plans to account for the current issues and unmet patient needs
- Improve protocol design and patient recruitment efforts by incorporating socio-economic and treatment-specific messages into your plans
- Understand what types of physicians patients are seeing and what is impacting their medication treatment decisions
- And more See the full table of contents in this preview for a full list of topics covered in this report
- 209 patients in the United States who were screened for having chronic cluster headaches, tension headaches, or migraines completed a 30-minute web-based quantitative survey conducted by ISR.
- All survey questions were segmented by the three conditions analyzed, as well as by
- Type of insurance
- The patient’s likelihood of enrolling in a clinical trial
- Type of primary physician the patient is seeing for treatment
- Length of time since diagnosis
- Severity of symptoms
- Age
- Household income
- Number of treatments
- Type of treatment

Table Of Contents

Headaches: Current Treatments, Unmet Needs, and Patient Recruitment
Table of Contents

Copyright and Usage Guidelines ..7
Introduction .8
Methodology ...9
Executive summary 12
Infographic 13
Analyzed segments ...14
Clinical trial patient recruitment summary ...22
Conditions segment .26
Number of treatments segment ..26
Current treatments segment ...27
Age segment 27
Treatment satisfaction ..28
What patients want the pharmaceutical industry to know ..29
Segment differences 32
Gender segment .32
Age segment ...32
Conditions segment 33
Length of time since diagnosis segment .33
Likelihood of enrolling in a clinical trial ...34
Headache profiles ..35
Headaches per month ...36
Headaches with aura .37
Segment differences 37
Gender segment .37
Conditions segment 38
Headache severity segment ...38
Likelihood of enrolling in a clinical trial ..39
Family history 40
Segment differences 40
Conditions segment 40
Length of time since diagnosis segment 41
Number of treatments segment 41
Likelihood of enrolling in a clinical trial ..42
Pain frequency ..43
Segment differences ...44
Conditions segment 44
Headache severity segment ...44
Number of treatments segment .45
Current treatments segment ..45
Likelihood of enrolling in a clinical trial ..46
Headache severity 47
Segment differences ...48
Current treatments segment ..48
Likelihood of enrolling in a clinical trial ..48
Health conditions ...49
Physical ability satisfaction ...50
Segment difference ..51
Income segment .51
Length of time since diagnosis segment .51
Number of treatments segment 52
Insurance segment .52
Overall health status .53
Segment difference ..54
Income segment ..54
Headache severity segment .54
Likelihood of enrolling in a clinical trial 55
Quality of life 56
Segment differences 57
Ability to walk or move around ...57
Age segment ...57
Conditions segment 57
Headache severity segment 58
Length of time since diagnosis segment .58
Current treatments segment ..59
Normal work life ..60
Age segment ...60
Income segment .60
Headache severity ..61
Number of treatments segment ..62
Insurance provider segment ...62
Primary physician type segment ..63
Current treatments segment ..64
Normal family life ...65
Age segment ...65
Conditions segment 65
Headache severity segment 66
Current treatments segment ..67
Recreational activities ..68
Age segment ...68
Headache severity segment ...68
Number of treatments segment 69
Insurance provider segment ..69
Current treatments segment .70
Sleep 71
Headache severity segment ...71
Current treatments segment ..71
Likelihood of enrolling in a clinical trial ..72
Mood ...73
Age segment ...73
Insurance segment ..73
Current treatments segment ..74
Enjoyment of life ..75
Age segment ...75
Conditions segment 75
Headache severity segment ...76
Length of time since diagnosis segment 76
Insurance provider segment ..77
Likelihood of enrolling in a clinical trial ..77
Unmet needs, symptoms and triggers ...78
Biggest unmet need ..79
Segment differences 80
Gender segment .80
Age segment ..82
Headache severity segment ...83
Commonly experienced symptoms ..84
Most difficult symptom 86
Segment differences ...87
Gender segment 87
Conditions segment ...88
Length of time since diagnosis segment 89
Current treatments segment .90
Common triggers ...91
Most common trigger ..93
Segment differences 95
Age segment ...95
Length of time since diagnosis segment .96
Likelihood of enrolling in a clinical trial ...97
Diagnosis metrics ...98
Time elapsed since diagnosis 99
Time from first symptoms to diagnosis ..100
Misdiagnosis of ailment ..101
Segment differences .102
Headache severity segment .102
Insurance provider segment 102
Likelihood of enrolling in a clinical trial 103
Diagnosing physician ...104
Segment differences ..105
Conditions segment ..105
Primary physician type segment ..106
Additional opinions sought? ...107
Segment differences ..107
Current treatments segment 107
Physician use 108
Healthcare providers for headache treatment ...109
Primary health care provider for headaches treatment .110
Segment differences ..111
Primary physician type segment ...111
Current treatments segment 112
Personal medication research 113
Segment differences ..114
Age segment .114
Likelihood of enrolling in a clinical trial 114
Sources influencing medication choice ...115
Current treatment regimens 116
Current and past treatment regimens 117
Additional medications ...119
Most effective medication ..120
Segment differences ..122
Number of treatments segment ...122
Goals of medication regime 123
Current treatments segment 124
Satisfaction with current treatment regimen .125
Segment differences ..126
Current treatments segment 126
Conditions segment ..126
Income segment ...127
Satisfaction with various aspects of current medication regimen ..128
Segment differences ..129
Ease of use/ administration ..129
Current treatments segment 129
Conditions segment ..130
Cost .131
Current treatments segment 131
Conditions segment ..132
Side effects ..133
Conditions segment ..133
Number of treatments segment ...133
Current treatments segment 134
Effectiveness ...135
Income segment ...135
Current treatments segment 135
Conditions segment ..136
Patients' desired treatment improvements ...137
Segment differences ..138
Length of time since diagnosis segment ...138
Number of treatments segment ...138
Current treatments segment 139
Most debilitating side effects .140
Insurance issues ..142
Likelihood of enrolling in a clinical trial ...143
Segment differences ..145
Conditions segment ..145
Number of treatments segment ...145
Current treatments segment 146
What patients want the pharmaceutical industry to know 147
Segment differences ..149
Gender segment ...149
Age segment .149
Conditions segment ..150
Length of time since diagnosis segment ...150
Respondent demographics ..151
Age ..152
Gender 153
Race/ ethnicity 154
Medical conditions ..155
Headache severity ...156
Education level 157
Household income ..158
Health insurance .159
About Industry Standard Research ..160

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

Ulcerative Colitis: Kol Insight

September 2016 $ 8085

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy Market in Europe

  • November 2016
    19 pages
  • Therapy  

  • Europe  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Therapy Market in the US - Forecast

  • November 2016
    6 pages
  • Therapy  

    Opioid  

  • United States  

View report >

Related Market Segments :

Therapy

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.